Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
25.31
-0.34 (-1.33%)
Nov 6, 2026, 4:00 PM EST - Market closed
Neurogene Market Cap
Neurogene has a market cap or net worth of $506.49 million as of November 6, 2026. It is the 14,168th most valuable company in the world and the 2,694th biggest in the United States. Its market cap has increased by 28.02% in one year.
Market Cap
506.49M
Enterprise Value
289.44M
1-Year Change
28.02%
Global Rank
Country Rank
#2,694 United States
Category
ChartMarket Cap Chart
Since December 19, 2023, Neurogene's market cap has increased from $193.64M to $506.49M, an increase of 161.56%. That is a compound annual growth rate of 39.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 506.49M | 58.73% |
| Dec 31, 2025 | 319.09M | -6.03% |
| Dec 31, 2024 | 339.58M | 36.64% |
| Dec 29, 2023 | 248.52M | 28.34% |
| Dec 19, 2023 | 193.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SL Science Holding | 534.62M |
| Valneva SE | 530.74M |
| Capricor Therapeutics | 523.25M |
| Gyre Therapeutics | 520.99M |
| Indaptus Therapeutics | 509.89M |
| DiaMedica Therapeutics | 504.74M |
| REGENXBIO | 503.85M |
| Electra Therapeutics | 489.58M |